(Q73925006)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10867329%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

0 references

1 reference

title

Statins after cardiac transplantation: which statin, what dose, and how low should we go? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10867329%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

author name string

C M Ballantyne

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10867329%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

publication date

1 June 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10867329%20AND%20SRC:MED&resulttype=core&format=json

The Journal of Heart and Lung Transplantation

7 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10867329%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10867329%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10867329%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

515-517

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10867329%20AND%20SRC:MED&resulttype=core&format=json

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900125-X

7 January 2021

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900125-X

7 January 2021

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900125-X

7 January 2021

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900125-X

7 January 2021

The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900125-X

7 January 2021

Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900125-X

7 January 2021

Rhabdomyolysis in patients receiving lovastatin after cardiac transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900125-X

7 January 2021

Rhabdomyolysis and renal injury with lovastatin use. Report of two cases in cardiac transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900125-X

7 January 2021

Hyperlipidemia after heart transplantation: report of a 6-year experience, with treatment recommendations

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900125-X

7 January 2021

Treatment of hyperlipidemia after heart transplantation and rationale for the Heart Transplant Lipid Registry

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900125-X

7 January 2021

Accumulation of lovastatin, but not pravastatin, in the blood of cyclosporine-treated kidney graft patients after multiple doses

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900125-X

7 January 2021

Metabolism and drug interactions of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in transplant patients: are the statins mechanistically similar?

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900125-X

7 January 2021

Evaluation of fluvastatin in the treatment of hypercholesterolemia in renal transplant recipients taking cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900125-X

7 January 2021

Fluvastatin in combination with cyclosporin in renal transplant recipients: a review of clinical and safety experience

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900125-X

7 January 2021

Effect of pravastatin on outcomes after cardiac transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900125-X

7 January 2021

Simvastatin reduces graft vessel disease and mortality after heart transplantation: a four-year randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900125-X

7 January 2021

Cyclosporine plasma unbound fraction in heart and lung transplantation recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900125-X

7 January 2021

Reversal of lovastatin-mediated inhibition of natural killer cell cytotoxicity by interleukin 2.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900125-X

7 January 2021

10.1016/S1053-2498(00)00125-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10867329%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference